John M. Sprague - 20 Feb 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Financial Officer
Signature
/s/ Michael Gibbs, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
20 Feb 2024
Net transactions value
$0
Form type
4
Filing time
20 Feb 2024, 16:00:22 UTC
Previous filing
09 Mar 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +40 +56% 112 20 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +40 $0.000000 40 20 Feb 2024 Common Stok 40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On February 20, 2022 the reporting person was granted 120 RSU's that vest in three equal installments commencing on February 20, 2023.